Oki Masahide, Saka Hideo, Kumazawa Akifumi, Sako Chieko, Ando Maki, Watanabe Atsushi
Department of Respiratory Medicine, Nagoya National Hospital, Nagoya 460-0001, Japan.
Respiration. 2004 Sep-Oct;71(5):523-7. doi: 10.1159/000080639.
Transbronchial needle aspiration (TBNA) is used most frequently to assess subcarinal nodes because of its technical ease.
We conducted a prospective observational clinical study to define the indications for TBNA use for subcarinal nodes (transcarinal needle aspiration, TCNA) related to the nodal size by computed tomography (CT) of the chest.
One hundred and eight consecutive patients with lung cancer underwent TCNA at the time of initial diagnostic bronchoscopy within a 22-month period.
TCNA was positive in 21 of the patients. Only 1 of 75 patients (1%) with subcarinal nodes less than 10 mm in short-axis diameter by CT had a positive result. TCNA for enlarged nodes, 10 mm or greater, had a high positive yield of 61% (20/33). The procedure provided the only evidence of unresectable non-small cell lung cancer (stage IIIA-N2 disease) in 3 patients and the sole pathological evidence for malignancy in 5 patients.
The high yield of positive TCNA results for enlarged subcarinal nodes contributes to the improvement of the overall diagnostic yield of bronchoscopy. We recommend that TCNA for enlarged subcarinal nodes on CT in patients with presumptive lung cancer should be performed routinely at the time of initial diagnostic bronchoscopy.
经支气管针吸活检术(TBNA)因其操作简便,最常用于评估隆突下淋巴结。
我们进行了一项前瞻性观察性临床研究,以确定胸部计算机断层扫描(CT)显示的与淋巴结大小相关的隆突下淋巴结经隆突针吸活检术(TCNA)的应用指征。
在22个月内,108例连续的肺癌患者在初次诊断性支气管镜检查时接受了TCNA。
21例患者的TCNA结果为阳性。CT显示短轴直径小于10mm的75例隆突下淋巴结患者中只有1例(1%)结果为阳性。对于直径10mm及以上的肿大淋巴结,TCNA的阳性率高达61%(20/33)。该操作在3例患者中提供了不可切除的非小细胞肺癌(IIIA-N2期疾病)的唯一证据,在5例患者中提供了恶性肿瘤的唯一病理证据。
肿大的隆突下淋巴结TCNA阳性率高有助于提高支气管镜检查的总体诊断率。我们建议,对于疑似肺癌患者,在初次诊断性支气管镜检查时应常规对CT显示的肿大隆突下淋巴结进行TCNA。